Source: Abstracts. Conference titles: ISoP Annual Meeting "A New Era of Pharmacovigilance: Challenges and Opportunities". Unidade: FCF
Subjects: NEOPLASIAS DO TRATO RESPIRATÓRIO, GENÓTIPOS, VARIAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORIEL, Patricia et al. ABCB1 transporter allelic variants and dermatologic adverse reactions related to gefitinib therapy in lung cancer patients: a pilot study. 2022, Anais.. London: International Society of Pharmacovigilance/ISOP, 2022. . Acesso em: 03 jun. 2024.APA
Moriel, P., Morau, M. V., Seguin, C. M., Barbeiro, A. D. S., Zambon, L. M., Pincinato, E. de C., et al. (2022). ABCB1 transporter allelic variants and dermatologic adverse reactions related to gefitinib therapy in lung cancer patients: a pilot study. In Abstracts. London: International Society of Pharmacovigilance/ISOP.NLM
Moriel P, Morau MV, Seguin CM, Barbeiro ADS, Zambon LM, Pincinato E de C, Perroud Junior MW, Visacri MB. ABCB1 transporter allelic variants and dermatologic adverse reactions related to gefitinib therapy in lung cancer patients: a pilot study. Abstracts. 2022 ;[citado 2024 jun. 03 ]Vancouver
Moriel P, Morau MV, Seguin CM, Barbeiro ADS, Zambon LM, Pincinato E de C, Perroud Junior MW, Visacri MB. ABCB1 transporter allelic variants and dermatologic adverse reactions related to gefitinib therapy in lung cancer patients: a pilot study. Abstracts. 2022 ;[citado 2024 jun. 03 ]